Amgen Inc financial data

Symbol
AMGN on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
One Amgen Center Drive, Thousand Oaks, CA
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-K - Q4 2024 - Feb 14, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 131 % -48.8%
Quick Ratio 36.7 % -0.25%
Return On Equity 67.2 % -34.9%
Return On Assets 4.46 % -39%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 537M shares +0.24%
Common Stock, Shares, Outstanding 537M shares +0.28%
Entity Public Float 168B USD +41.4%
Weighted Average Number of Shares Outstanding, Basic 537M shares +0.37%
Weighted Average Number of Shares Outstanding, Diluted 541M shares +0.56%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 33.4B USD +18.6%
Costs and Expenses 26.2B USD +28.9%
Operating Income (Loss) 7.26B USD -8.09%
Nonoperating Income (Expense) 506M USD -82.1%
Income Tax Expense (Benefit) 519M USD -54.4%
Net Income (Loss) Attributable to Parent 4.09B USD -39.1%
Earnings Per Share, Basic 7.62 USD/shares -39.3%
Earnings Per Share, Diluted 7.56 USD/shares -39.5%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 12B USD +9.4%
Accounts Receivable, after Allowance for Credit Loss, Current 6.78B USD -6.69%
Inventory, Net 7B USD -26.5%
Other Assets, Current 3.28B USD +25.9%
Assets, Current 29B USD -4.29%
Property, Plant and Equipment, Net 6.54B USD +10.1%
Operating Lease, Right-of-Use Asset 557M USD -14.4%
Intangible Assets, Net (Excluding Goodwill) 27.7B USD -15.1%
Goodwill 18.6B USD +0.04%
Other Assets, Noncurrent 9.93B USD +3.32%
Assets 91.8B USD -5.47%
Accounts Payable, Current 1.91B USD +20%
Employee-related Liabilities, Current 1.33B USD -3.77%
Accrued Liabilities, Current 17.6B USD +14.9%
Liabilities, Current 23.1B USD +25.6%
Deferred Income Tax Liabilities, Net 1.62B USD -31.4%
Operating Lease, Liability, Noncurrent 673M USD -2.61%
Other Liabilities, Noncurrent 2.35B USD +0.99%
Common Stocks, Including Additional Paid in Capital 33.5B USD +1.4%
Accumulated Other Comprehensive Income (Loss), Net of Tax -66M USD +77.2%
Retained Earnings (Accumulated Deficit) -27.6B USD -3.92%
Stockholders' Equity Attributable to Parent 5.88B USD -5.7%
Liabilities and Equity 91.8B USD -5.47%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 689M USD -35.2%
Net Cash Provided by (Used in) Financing Activities -1.71B USD -108%
Net Cash Provided by (Used in) Investing Activities -217M USD -116%
Common Stock, Shares Authorized 2.75B shares 0%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -1.24B USD -105%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 12B USD +9.4%
Deferred Tax Assets, Valuation Allowance 1.02B USD +6.48%
Deferred Tax Assets, Gross 6B USD +8.78%
Operating Lease, Liability 780M USD -3.7%
Payments to Acquire Property, Plant, and Equipment 230M USD -33.1%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent 4.31B USD -35.2%
Lessee, Operating Lease, Liability, to be Paid 941M USD -3.69%
Property, Plant and Equipment, Gross 16.9B USD +7.51%
Operating Lease, Liability, Current 107M USD -10.1%
Lessee, Operating Lease, Liability, to be Paid, Year Two 129M USD +6.61%
Lessee, Operating Lease, Liability, to be Paid, Year One 110M USD -20.3%
Operating Lease, Weighted Average Discount Rate, Percent 0.04 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 161M USD -3.59%
Lessee, Operating Lease, Liability, to be Paid, Year Three 112M USD +2.75%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 5M shares 0%
Unrecognized Tax Benefits 4.18B USD +4.29%
Lessee, Operating Lease, Liability, to be Paid, Year Four 91M USD -4.21%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 4.8B USD +50%
Depreciation, Depletion and Amortization 1.4B USD +55.4%
Deferred Tax Assets, Net of Valuation Allowance 4.98B USD +9.27%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%